A phase II, open label, randomised trial of ipilimumab and nivolumab with concurrent intracranial stereotactic radiotherapy versus ipilimumab and nivolumab alone in patients with melanoma brain metastases.

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

Effective start/end date29/07/2028/02/25


  • Medical oncology
  • Melanoma brain metastasis
  • Clinical trial